Mercer Global Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$937K Buy
5,732
+165
+3% +$25.4K ﹤0.01% 1599
2025
Q4
$969K Buy
5,567
+2,045
+58% +$373K ﹤0.01% 1474
2025
Q3
$507K Buy
3,522
+1,098
+45% +$135K ﹤0.01% 1749
2025
Q2
$244K Buy
+2,424
New +$185K ﹤0.01% 1970
2025
Q1
Sell
-3,281
Closed -$227K 2208
2024
Q4
$227K Buy
+3,281
New +$236K ﹤0.01% 1901

Other funds holding INSM

Mercer Global Advisors's INSM Position: Q1 2026 in Review

Mercer Global Advisors increased its Insmed (INSM) stake by 3% in Q1 2026, buying an estimated $25.4K and bringing the position to 5,732 shares worth $937K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Mercer Global Advisors first reported a position in INSM in Q4 2024 and has held it in 5 quarters since. The position peaked at $969K in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Mercer Global Advisors held 5,732 shares of Insmed worth $937K as of Q1 2026.
  • Mercer Global Advisors bought 165 Insmed shares in Q1 2026, an estimated $25.4K.
  • Insmed made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #1599 holding.
  • Mercer Global Advisors first reported a position in Insmed in Q4 2024 and has held it in 5 quarters since.
  • Mercer Global Advisors's Insmed position peaked at $969K in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.